GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yuhan Corp (XKRX:000100) » Definitions » Cyclically Adjusted PB Ratio

Yuhan (XKRX:000100) Cyclically Adjusted PB Ratio : 3.21 (As of Jun. 05, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Yuhan Cyclically Adjusted PB Ratio?

As of today (2024-06-05), Yuhan's current share price is ₩79600.00. Yuhan's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩24,814.90. Yuhan's Cyclically Adjusted PB Ratio for today is 3.21.

The historical rank and industry rank for Yuhan's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:000100' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.52   Med: 2.25   Max: 3.38
Current: 2.77

During the past years, Yuhan's highest Cyclically Adjusted PB Ratio was 3.38. The lowest was 1.52. And the median was 2.25.

XKRX:000100's Cyclically Adjusted PB Ratio is ranked worse than
63.84% of 730 companies
in the Drug Manufacturers industry
Industry Median: 1.885 vs XKRX:000100: 2.77

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Yuhan's adjusted book value per share data for the three months ended in Mar. 2024 was ₩27,435.380. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩24,814.90 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Yuhan Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Yuhan's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yuhan Cyclically Adjusted PB Ratio Chart

Yuhan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.10 3.30 2.63 2.36 2.80

Yuhan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.05 2.41 2.95 2.80 3.09

Competitive Comparison of Yuhan's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yuhan's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Yuhan's Cyclically Adjusted PB Ratio falls into.



Yuhan Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Yuhan's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=79600.00/24814.9
=3.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yuhan's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Yuhan's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=27435.38/118.8477*118.8477
=27,435.380

Current CPI (Mar. 2024) = 118.8477.

Yuhan Quarterly Data

Book Value per Share CPI Adj_Book
201406 16,528.043 99.353 19,771.118
201409 16,791.741 99.608 20,035.136
201412 16,872.591 99.098 20,235.208
201503 16,947.266 99.720 20,197.990
201506 17,352.328 100.050 20,612.536
201509 17,947.571 100.110 21,306.838
201512 18,098.450 100.220 21,462.374
201603 18,514.156 100.560 21,881.114
201606 19,023.991 100.790 22,432.360
201609 19,347.220 101.460 22,662.848
201612 20,836.738 101.560 24,383.600
201703 19,931.988 102.850 23,032.289
201706 20,301.260 102.610 23,513.869
201709 20,623.626 103.490 23,684.129
201712 22,071.221 102.990 25,469.598
201803 21,045.292 104.100 24,026.749
201806 21,308.143 104.130 24,319.829
201809 21,411.268 105.650 24,085.944
201812 22,738.553 104.350 25,897.697
201903 21,579.630 104.490 24,544.831
201906 21,534.304 104.880 24,402.198
201909 21,650.295 105.200 24,459.009
201912 22,853.537 105.120 25,837.998
202003 22,902.311 105.540 25,790.098
202006 23,686.621 104.870 26,843.715
202009 24,510.584 106.200 27,429.628
202012 25,552.897 105.765 28,713.578
202103 24,542.082 107.357 27,168.834
202106 24,905.695 107.579 27,514.622
202109 25,203.179 108.759 27,541.025
202112 26,845.402 109.676 29,090.254
202203 25,214.239 111.806 26,802.315
202206 25,502.367 114.083 26,567.525
202209 25,541.023 114.831 26,434.359
202212 27,759.900 115.200 28,638.841
202303 26,286.629 116.550 26,804.943
202306 26,130.506 117.140 26,511.467
202309 26,403.424 119.111 26,345.014
202312 28,707.736 118.848 28,707.736
202403 27,435.380 118.848 27,435.380

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Yuhan  (XKRX:000100) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Yuhan Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Yuhan's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Yuhan (XKRX:000100) Business Description

Traded in Other Exchanges
Address
74, Noryangjin-ro, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplement, household and animal care, and contract manufacturing of active pharmaceutical ingredients. Yuhan offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.

Yuhan (XKRX:000100) Headlines

No Headlines